Copy number variations in esophageal squamous cell carcinoma: Emerging cancer drivers and biomarkers (Review).
copy number variations
driver gene
esophageal squamous cell carcinoma
potential target
Journal
Oncology reports
ISSN: 1791-2431
Titre abrégé: Oncol Rep
Pays: Greece
ID NLM: 9422756
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
received:
12
01
2023
accepted:
22
09
2023
medline:
20
11
2023
pubmed:
17
11
2023
entrez:
17
11
2023
Statut:
ppublish
Résumé
The morbidity and mortality of esophageal squamous cell carcinoma (ESCC) remains high in China. ESCC is significantly influenced by a complex interplay of environmental and genetic factors. Copy number variations (CNVs) are a major form of genome‑scale changes in ESCC and are closely related to tumorigenesis and development. Genome‑wide detection and analysis allow the identification of important CNV‑affected genes with potential clinical applications. In both coding and non‑coding regions, CNVs have been identified frequently in certain segments of chromosomes. CNV‑impacted genes have crucial roles in multiple cellular processes, including proliferation, apoptosis, metastasis, and metabolic pathways. More importantly, they may serve as potential therapeutic targets for patients with ESCC. Therefore, studying the role of CNVs in ESCC is helpful to explore the pathogenesis of ESCC and to find effective treatment targets, which have profound implications for the diagnosis and therapy of ESCC.
Identifiants
pubmed: 37975224
doi: 10.3892/or.2023.8667
pii: 8
doi:
pii:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM